Rosy outlook for healthcare sector

RHB Research expects organic expansion and a pick-up in merger and acquisition activities to drive healthcare sector growth in 2024

PETALING JAYA: Amid some downside risks, the outlook of the healthcare sector for 2024 remains bright.

RHB Research said it is maintaining its “overweight” call on the sector given the relatively inelastic demand trends, coupled with rising health awareness, and a rapidly ageing society to anchor generic drug makers’ mid-to-longer-term prospects.